Recent advances in pathophysiology and treatment of hypercalcemia of malignancy (Q38656046)

5 September 2017

1 reference

title

Recent advances in pathophysiology and treatment of hypercalcemia of malignancy (English)

1 reference

5 September 2017

1 reference

G R Mundy

1

1 reference

5 September 2017

A J Yates

series ordinal

2

1 reference

5 September 2017

publication date

1 July 1989

1 reference

American Journal of Kidney Diseases

5 September 2017

published in

1 reference

5 September 2017

volume

14

1 reference

5 September 2017

issue

1

1 reference

5 September 2017

page(s)

2-12

1 reference

Vitamin D deficiency and renal calcium transport in the rat

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Effect of calcitonin and glutocorticoids in combination on the hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

The hypercalcemia of malignancy: pathogenesis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

The hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Hypercalcemia of malignancy revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Quantitative bone histology in the hypercalcemia of malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Quantitative histology of myeloma-induced bone changes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

PLASMA-CHLORIDE LEVELS IN HYPERPARATHYROIDISM AND OTHER HYPERCALCAEMIC STATES

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Malignancy-Associated Hypercalcemia: Evaluation with a Cytochemical Bioassay for Parathyroid Hormone*

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Circulating 1,25-dihydroxyvitamin D concentrations in patients with renal cell carcinoma-associated hypercalcemia are rarely suppressed

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Parathyroid hormone-related protein purified from a human lung cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Parathyroid hormone-related protein of malignancy: active synthetic fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

A parathyroid hormone-like protein from cultured human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Expression of a calcium-mobilizing parathyroid hormone-like peptide in lactating mammary tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Rat Transforming Growth Factor Type 1: Structure and Relation to Epidermal Growth Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Developmental expression of rat transforming growth factor-alpha mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Stimulation of bone resorption in vitro by synthetic transforming growth factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Human transforming growth factor-alpha stimulates bone resorption in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

1 reference

7 January 2021

Production of interleukin-1 alpha and a parathyroid hormone-like factor by a squamous cell carcinoma of the esophagus (EC-GI) derived from a patient with hypercalcemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

An interleukin 1 like factor stimulates bone resorption in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Pig interleukin 1 (catabolin) is a potent stimulator of bone resorption in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Prostaglandins: stimulation of bone resorption in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6-oxo-E1

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Hypercalcemia and tumor-prostaglandins: The VX2 carcinoma model in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Comparative study of available medical therapy for hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Production of 1,25-dihydroxyvitamin D3 by human T cell lymphotrophic virus-I-transformed lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Identification of 1,24(R)-dihydroxyvitamin D3-like bone-resorbing lipid in a patient with cancer-associated hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Influence of urinary sodium excretion on the clinical assessment of renal tubular calcium reabsorption in hypercalcaemic man.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Acute treatment of hypercalcemia with furosemide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

The effect of furosemide on hypercalcemia due to dihydrotachysterol

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Therapy of hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Renal failure associated with intravenous diphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

A comparison of single and multiple intravenous infusions of 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate (APD) in the treatment of hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Treatment of cancer-associated hypercalcemia with cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

Normalization of hypercalcemia associated with a decrease in renal calcium reabsorption in Leydig cell tumor-bearing rats treated with WR-2721.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2889%2980086-1

7 January 2021

10.1016/S0272-6386(89)80086-1

Identifiers

DOI

1 reference

5 September 2017

1 reference